NTRA vs. FMS, DGX, OPCH, PACS, HIMS, GH, AGL, FTRE, NHC, and VCYT
Should you be buying Natera stock or one of its competitors? The main competitors of Natera include Fresenius Medical Care (FMS), Quest Diagnostics (DGX), Option Care Health (OPCH), PACS Group (PACS), Hims & Hers Health (HIMS), Guardant Health (GH), agilon health (AGL), Fortrea (FTRE), National HealthCare (NHC), and Veracyte (VCYT). These companies are all part of the "medical" sector.
Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation.
Fresenius Medical Care has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.
Natera received 47 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.56% of users gave Natera an outperform vote while only 54.29% of users gave Fresenius Medical Care an outperform vote.
8.3% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Fresenius Medical Care has a net margin of 2.48% compared to Fresenius Medical Care's net margin of -30.24%. Natera's return on equity of 5.29% beat Fresenius Medical Care's return on equity.
Fresenius Medical Care currently has a consensus price target of $24.00, indicating a potential upside of 18.23%. Natera has a consensus price target of $101.19, indicating a potential downside of 1.44%. Given Natera's higher probable upside, equities research analysts plainly believe Fresenius Medical Care is more favorable than Natera.
In the previous week, Natera had 18 more articles in the media than Fresenius Medical Care. MarketBeat recorded 22 mentions for Natera and 4 mentions for Fresenius Medical Care. Natera's average media sentiment score of 0.60 beat Fresenius Medical Care's score of 0.42 indicating that Fresenius Medical Care is being referred to more favorably in the media.
Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.
Summary
Fresenius Medical Care and Natera tied by winning 9 of the 18 factors compared between the two stocks.
Get Natera News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
